Science for Life.
ProPhase Labs develops and markets clinically proven remedies including the highly effective Cold-EEZE® and Kids-EEZE® product lines. Our ongoing objective is to deliver long-term value by providing exceptional new products that address the health care and quality of life concerns of the broadest market segments.
August 12, 2015 - ProPhase Labs Reports Financial Results for the Three and Six Months Ended June 30, 2015
August 05, 2015 - ProPhase Establishes 3.2 Million Share Equity Line
March 25, 2015 - ProPhase Labs Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2014
The Cold-EEZE® family of lozenges are clinically proven to reduce the duration of the common cold.